Company intelligence / Profile preview

T1D Exchange

Boston, Massachusetts, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

T1D Exchange is a non-profit research organization dedicated to accelerating therapies and improving care for individuals living with type 1 diabetes (T1D). The organization manages the largest T1D-specific clinical data registry in the United States, facilitating real-world evidence generation and clinical trial recruitment. Through its Quality Improvement Collaborative, T1D Exchange partners with over 50 endocrine clinics to standardize and enhance clinical outcomes. The platform serves as a bridge between patients, clinicians, and industry partners to drive innovation in diabetes management and technology.

Therapeutic areas: Endocrinology
Industry: Academic Hospital/University/Research

Partnerships

The Leona M. and Harry B. Helmsley Charitable TrustEli LillyNovo NordiskSanofiDexcomAbbottMedtronic

Beyond the preview

Go deeper on T1D Exchange.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on T1D Exchange.

Explore the full profile